Automated Non-Invasive Arterial Pressure Device in Normals and in Patients with Peripheral Arterial Disease

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 07-008523
    Sponsor Protocol Number: 07-008523

About this study

The purpose of this study is to determine the accuracy of an automated non-invasive arterial pressure device when assessing people with peripheral arterial disease.   The arterial pressure from each limb and calculated ABI’s from standard non-invasive arterial vascular testing verses automated non-invasive arterial device will be compared.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:          

  • Patients referred to the Non-invasive Vascular Laboratory that have arterial studies to assess for atherosclerosis.

Exclusion Criteria:         

  • Patients unable to have non-invasive vascular arterial studies to assess for atherosclerosis.

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Thom Rooke, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Thom Rooke M.D.

(507)266-7457

.
CLS-20313396

Mayo Clinic Footer